Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Total return indices show comprehensive performance by including dividends. Understanding them helps investors assess risk and compare strategies effectively.
27,899 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
The SEC and CFTC announced a formal partnership to harmonize crypto regulation and pursue new digital asset products....
A five-year AI infrastructure deal worth up to $27 billion between Nebius and Meta sparked a broad rally in lumentum,...
CF Industries has surged this year on supply constraints and cost advantages, yet a DOJ probe adds regulatory risk th...
The bond market nearing threshold as long-term yields climb in a period of geopolitical tension and data surprises. T...
CrowdStrike delivered a solid ARR beat but guided below lofty expectations, triggering a about 7% drop in CRWD shares...
Lam Research shares jump on stronger AI-related demand for semiconductor equipment. With foundries expanding capacity...
The S&P 500 fell as fresh inflation data surprised to the upside, triggering a broad risk-off move and reshaping near...
Florida challenges to the Rooney Rule intensify a national debate over DEI policies in sports. Investors and sponsors...
Artificial intelligence is accelerating the disruption of pharmacy benefit managers, reshaping margins and creating n...
Wells Fargo lowers Amazon's price target to $312 while keeping an Overweight rating, highlighting AWS as the core eng...
Investors are pricing rate hikes through 2027 as the Fed cuts outlook fades, reshaping bond yields and stock valuatio...